Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety, Pharmacokinetics and Efficacy of Four Doses of YN968D1 in Subjects With Solid Tumors

NCT01497704 is registered in ClinicalTrials.gov with Elevar Therapeutics as lead sponsor.

NCT NCT01497704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01497704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety, Pharmacokinetics and Efficacy of Four Doses of YN968D1 in Subjects With Solid Tumors
Lead sponsor
Elevar Therapeutics
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2012
Completion date
May 31, 2015
Enrollment
55 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer patients with solid tumors